The multicatalytic endopeptidase complex (proteasome) 
INTRODUCTION
The multicatalytic proteinase complex or proteasome (multicatalytic endopeptidase complex, EC 3.4.99.46) is a highmolecular-mass nonlysosomal proteinase of eukaryotic cells (Orlowski, 1990; Tanaka et al., 1992; Rivett, 1993) . The proteinase can cleave peptide bonds on the carboxy side of hydrophobic, basic or acidic amino acid residues, and these activities have been referred to as 'chymotrypsin-like', 'trypsinlike' and 'peptidylglutamyl-peptide hydrolase' activities respectively (Orlowski, 1990) . Mammalian proteasomes are now believed to contain at least five distinct catalytic components , the activities of which can be distinguished by assessing the effects of activators and inhibitors of proteolytic activity (Orlowski and Michaud, 1989; Rivett, 1989b; Cardozo et al., 1992; . For the rat liver enzyme, the catalytic components include one catalysing trypsin-like activity, two catalysing the hydrolysis of substrates for chymotrypsin-like activity, and two catalysing the so-called 'peptidylglutamyl-peptide hydrolase' activity. We have referred to the latter two components as LLE1 and LLE2 because both are able to hydrolyse the synthetic substrate benzyloxycarbonyl (Cbz)-Leu-Leu-Glu-,/-naphthylamide (Nap). They can be distinguished easily because LLE2 is inhibited by the serine-proteinase inhibitor, 3,4-dichloroisocoumarin, while LLE1 is unaffected. The other activities can be assayed individually using an appropriate substrate. Rather ases, the results provide useful information concerning the specificity of the distinct catalytic centres of proteasomes, and some selective affinity-labelling reagents have been identified. Tyr-Gly-Arg-chloromethane was found to be a useful inhibitor of trypsin-like activity. Inhibition of the other peptidase activities was often incomplete, even after repeated addition of inhibitor, and it proved to be difficult to predict the effect of different reagents. For example, Cbz-Tyr-Ala-Glu-chloromethane was found to inhibit 'chymotrypsin-like' activity (assayed with AlaAla-Phe-7-amino-4-methylcoumarin or succinyl-Leu-LeuVal-Tyr-7-amino-4-methylcoumarin), while the best inhibitors of 'peptidylglutamyl-peptide hydrolase' activities (assayed with benzyloxycarbonyl-Leu-Leu-Glu ,-naphthylamide) were peptidyldiazomethanes containing hydrophobic amino acid residues. These results suggest that the original nomenclature of proteasome activities is misleading, because the residue in the P1 position is not the only determinant of specificity.
little is known about the precise specificity of any of the catalytic components of the complex.
For several years the assignment of proteasomes into the class of serine or cysteine proteinases was a controversial issue because they were often found to be largely unaffected by the serineprotease inhibitor di-isopropyl fluorophosphate, but were sensitive to inhibition by thiol-reactive reagents (Rivett, 1989a) . However, the demonstration that at least some activities of proteasomes are effectively inhibited by the serine-protease inhibitors 3,4-dichloroisocoumarin (Orlowski and Michaud, 1989; Mason, 1990; and 4-(2-aminoethyl)benzenesulphonic acid has favoured the former classification. The lack of sequence similarity to other known proteases (Tanaka et al., 1992; Rivett, 1993) suggests that proteasomes belong to a novel family of peptidases.
The purpose of the present study was to learn more about the specificity and reactivity of the different catalytic centres of the complex, and also to identify suitable reagents for the identification of catalytic components and residues responsible for these activities. Peptidylchloromethanes, peptidyldiazomethanes, peptidylsulphonium salts and peptidylfluoromethanes have been used successfully as affinity-labelling reagents for many serine and/or cysteine proteinases (Shaw, 1984 (Shaw, , 1990 . In the present study, reagents designed to inhibit proteinases having a preference for hydrophobic, basic or acidic amino acid residues in the P1 position have been tested for inhibition of proteasome activities. It seems, from kinetic studies with synthetic fluorogenic (McGuire and DeMartino, 1986; Rivett, 1989b Kettner and Shaw (1981) , except those containing tyrosine, which were prepared as described by Rauber et al. (1988) . Cbz-Tyr-Ala-Glu-chloromethane (CH2CI) and Cbz-Leu-LeuGlu-CH2Cl were synthesized as described below.
Cbz-Leu-Tyr fluoromethane (CH2F) was obtained as described by Angliker et al. (1989) . The peptidylsulphonium salts containing arginine were described by Zumbrunn et al. (1988) , whereas the synthesis of the derivative of Cbz-Leu-Tyr has not been published yet (but details can be obtained from H. A. or E. S. on request). Peptidyl diazomethanes Cbz-Phe-Ala-diazomethane (CHN2) and Cbz-Ala-Phe-Ala-CHN2 were synthesized as described by Watanabe et al. (1979) , and Cbz-Leu-Trp-CHN2, Cbz-Phe-benzylserine [Ser(Bzl)]-Leu-Tyr-CHN2 and Boc-ValLys(Cbz)-Leu-Tyr-CHN2 were prepared as described by Crawford et al. (1988) ; Cbz-Ala-Ala-Leu-CHN2as described by Green and Shaw (1981) ; Cbz-Phe-Gly-Tyr-CHN2 as described below.
Synthesis of Cbz-Phe-Gly-Tyr-CHN2
Cbz-Phe-GlyOH was activated as the hydroxysuccinimide ester with dicyclohexyl carbodi-imide in the standard fashion and allowed to react with tyrosine in aq. 50% dioxan with added NaHCO3 to provide Cbz-Phe-Gly-Tyr. The blocked tripeptide was converted into the mixed anhydride and added to ethereal diazomethane to form the peptidyldiazomethane. The neutral product was chromatographed on Kieselgel in chloroform containing 2% methanol and crystallized from ethyl acetate to provide material of m.p. 117-118 'C. Analysis: calculated for C29H29N506 (543.6): C, 64.02; H, 5.38; N, 12.88; found: C, 63.83; H, 5.69; N, 12.56 .
The remaining diazomethanes which have not been described previously were obtained by a similar procedure.
Synthesis of Cbz-Tyr-Ala-Glu-CH2CI and Cbz-Leu-Leu-Glu-CH2CI
Glutamic acid was incorporated as the y-O-t-butyl ester (O-tBu), which was maintained through the tripeptide diazomethane stage, but finally deblocked with HCI during the conversion into the chloromethane. Thus Cbz-Tyr-Ala-succinyl ester (OSu) Proteinase purffication and assays Proteasomes were purified from fresh or frozen rat livers (Rivett and Sweeney, 1991) . Protein determinations were carried out by the method of Bradford (1976) , with BSA as standard. This method gives a very good approximation to actual proteasome concentration (Savory and Rivett, 1993) . The proteinase was assayed as described previously in 50 mM Hepes/KOH buffer, pH 7.5 (Rivett, 1989b; using the following substrates: 40,uM Boc-Leu-Ser-Thr-Arg-NH-Mec for trypsinlike activity, 40 ,M Ala-Ala-Phe-NH-Mec and Suc-Leu-LeuVal-Tyr-NH-Mec for the chymotrypsin-like activities, and 0.1 mM and 0.4 mM Cbz-Leu-Leu-Glu-Nap for peptidylglutamyl-peptide hydrolase activities. At 0.1 mM Cbz-Leu-LeuGlu-Nap the activity assayed is predominantly that of the LLE1 site, while at 0.4 mM, LLE2 is the major component .
Inhibitor studies
For initial studies of the effects of inhibitors, proteinase (20-40 ,ug/ml) was incubated with 0.1 mM inhibitor at 25 'C in 50 mM Hepes buffer, pH 7.0 or 7.5. Duplicate aliquots were removed after 0, 1 and 2 h, diluted at least 10-fold into 50 mM Hepes buffer, pH 7.5, containing the appropriate substrate for assays of proteinase activity (10-20 min at 37°C). The reversibility of the inhibition was tested by assaying activity following overnight dialysis to remove excess inhibitor. The stability of peptidyldiazomethane inhibitors was tested by measuring A277 before and after incubation with proteinase (Green and Shaw, 1981) . Cleavage of the peptidyl portion of inhibitors was tested in some cases by reverse-phase h.p.l.c. using a Vydac C18 column with a linear gradient of 0-70 % acetonitrile in 0.05 % trifluoroacetic acid.
RESULTS
Several peptidylchloromethanes with an arginine residue in the P1 position were tested for inhibition of Boc-Leu-Ser-Thr-Arg-NH-Mec hydrolysis (Table 1) . Glu-Gly-Arg-CH2Cl and TyrGly-Arg-CH2Cl both inhibited the trypsin-like activity in a timedependent and irreversible manner, whereas several other com- Table 1 Effect of affinity labels with a basic residue in P1 on trypsin-like activity of rat liver proteasomes Activities, assayed with Boc-Leu-Ser-Thr-Arg-NH-Mec after 1 h preincubation in 50 mM Hepes/KOH buffer, pH 7.5, as described in the Materials and methods section, are expressed as a percentage of the activity of proteinase assayed immediately after addition of affinity labels. The enzyme retained more than 95% of its activity during control incubations which contained no inhibitor. The results given are averages for at least two separate experiments. Ac is acetyl.
Concn.
Activity Reagent (mM) (% of value at to) Peptidylchloromethanes Ac-Gly-Gly-Arg-CH2CI Gln-Gly-Arg-CH2CI Glu-Gly-Arg-CH2CI
lle-Glu-Gly-Arg-CH2CI Tyr-Gly-Arg-CH2CI
Tyr-Phe-Arg-CH2CI
Peptidylsulphonium salts Bz-Phe-Arg-CH2S+(CH3)2
Ala-Arg-Arg-CH2S+(CH3)2 Peptidyldiazomethane Boc-Val-Leu-Gly-Lys-CHN2 Table 2 . Several inhibitors with hydrophobic residues in the P1 position, which might be expected to inhibit chymotrypsin-like activities assayed with Ala-Ala-Phe-NH-Mec and Suc-Leu-Leu-Val-Tyr-NH-Mec, were also found to inhibit peptidylglutamyl-peptide hydrolase activities assayed with CbzLeu-Leu-Glu-Nap ( Table 2) . Several of these affinity-labelling reagents, especially the diazomethanes, did inhibit proteasome activities in an irreversible, time-dependent, manner. There was no cleavage of the inhibitors tested, but in some cases a direct loss of diazo groups was observed (e.g. for Cbz-Phe-Gly-Tyr-CHN2; approx. 50 % in 3 h).
Cbz-Phe-Gly-TyrCHN2 was found to be an effective inhibitor of chymotrypsin-like activity assayed with either Ala-Ala-Phe-NH-Mec or Suc-Leu-Leu-Val-Tyr-NH-Mec, but it was impossible to achieve full inhibition even after repeated additions of inhibitor or long incubation times. Cbz-Leu-Leu-Tyr-CHN2 inhibited both chymotrypsin-like and peptidylglutamyl-peptide hydrolase activities, while, surprisingly, the chloromethane derivative of Cbz-Tyr-Ala-Glu did not affect the rate of hydrolysis of Cbz-Leu-Leu-Glu-Nap, but did inhibit the hydrolysis of AlaAla-Phe-NH-Mec and Suc-Leu-Leu-Val-Tyr-NH-Mec (Table 2) . Cbz-Leu-Leu-Glu-CH2Cl, which might be expected to selectively inhibit LLEl and LLE2 activities, also inhibited chymotrypsin- Table 2 Effect of Inhibitors with hydrophobic or acidic P1 residue on different proteasome activities All inhibitors were tested at a concentration of 0.1 mM. Activities given as percent of control where control incubations contained no inhibitor. Preincubation was for 1 h at 25 OC, pH 7.0, except where indicated by an asterisk, where preincubation was for 30 min at 25 OC. The enzyme retained more than 95% of its activity during control incubations containing no inhibitor. The results given are averages for at least two separate experiments. Abbreviations: nd, not determined; AAF-NH-Mec, Ala-Ala-Phe-NH-Mec; LLVY-NH-Mec, Suc-Leu-Leu-Val-Tyr-NH-Mec; LLE-Nap, Cbz-LeuLeu-Glu-Nap. Boc-Leu-Ser-Thr-Arg-N H-Mec Thr-Gly-Arg-CH2CI Boc-Val-Leu-Gly-Lys-CHN2 Ala-Ala-Phe-NH-Mec Cbz-Phe-Gly-Tyr-CHN2 Cbz-Tyr-Ala-Glu-CH2CI Suc-Leu-Leu-Val-Tyr-NH-Mec Cbz-Phe-Gly-Tyr-CH2Cl* Cbz-Phe-Gly-Tyr-CHN2 Cbz-Tyr-Ala-Glu-CH2Cl* Cbz-Leu-Leu-Glu-NA 0.1 mM Cbz-Leu-Leu-Tyr-CHN2 Cbz-Leu-Trp-CHN2 Assays were carried out as described in the Materials and methods section. 0, 5 ,tM CbzPhe-Gly-Tyr-CH2CI; El. 20 ,uM Ala-Ala-Phe-CH2CI; A, 100 1sM Cbz-Tyr-Ala-Glu-CH2CI. like activities. The most effective inhibitors of peptidylglutamylpeptide hydrolase activities were found to be those with hydrophobic residues in the P1 and P2 positions ( Table 2) .
The apparent second-order rate constants for inactivation of proteasome activities by some of the most effective irreversible inhibitors are shown in Table 3 . With Suc-Leu-Leu-Val-Tyr-NH-Mec as substrate, initial inactivation with several peptidylchloromethane inhibitors was very rapid (Figure 1 ), but no more than 50-70 % of the activity could be inhibited, even after further additions of the inhibitor. With the diazomethane derivative of Cbz-Phe-Gly-Tyr, the initial rate of inactivation was high, but again only partial inhibition was achieved. Where there was rapid but partial inactivation, the inhibition was also found to be time-dependent (as illustrated in Figure 1 ) and mostly, if not entirely, irreversible. However, some reversible and non-specific inhibition was observed with several of the reagents. This may be due to the high concentrations of reagents used, and this has been noted previously for the human liver proteinase (Mason, 1990 ). The reagents were not routinely tested at concentrations higher than 0.1 mM because of non-specific inhibition of several of the activities.
DISCUSSION
Chloromethanes are useful reagents for the alkylation of the catalytic histidine or serine residues of serine proteinases (Shaw, 1984) . Diazomethanes were initially believed to inhibit cysteine, but not serine, proteinases (Leary et al., 1977; Shaw, 1984 Shaw, , 1990 . However, later studies showed that the serine proteinase plasma kallikrein can be inhibited by peptidyldiazomethanes (Zumbrunn et al., 1988) , as can prolyl endopeptidase (Stone et al., 1992) . Chymotrypsin, on the other hand, is not inactivated by Cbz-AlaPheCHN2, but catalyses the disappearance of diazo groups, which can be monitored spectrophotometrically (Watanabe et al., 1979) .
The peptidase activities of purified rat liver proteasomes can be inhibited by a variety of peptidylchloromethanes and peptidyldiazomethanes in a time-dependent, irreversible, manner. The fact that several chloromethanes and diazomethanes were ineffective demonstrates that the choice of peptidyl portion of the inhibitor is important and explains the negative results of other studies of mammalian proteasomes in which only a few reagents were tested (Dahlmann et al., 1985; Mason, 1990; Cardozo et al., 1992) . It is very difficult to predict which reagents will be effective on the different peptidase sites. For example, the lack ofinhibition of Ala-Ala-Phe-NH-Mec hydrolysis by Ala-Ala-PheCH2Cl was particularly surprising.
Irreversible inhibition of proteasome activities by peptidylchloromethanes and peptidyldiazomethanes is consistent with the notion that the complex is an atypical serine proteinase (Mason, 1990; Orlowski et al., 1991; . The rates of inactivation with many of the reagents tested were low compared with those for some other serine proteinases, and in many cases it was not possible to achieve complete inhibition of an activity, even after repeated additions of inhibitor. Such observations could be explained by a lack of reactivity of catalytic residues in some catalytic centres with these affinity-labelling reagents, as found for a number of serine-proteinase inhibitors or simply reflect a poor choice of peptidyl portions of the inhibitor. Chymotrypsin-like activities of proteasomes, assayed with Ala-Ala-Phe-NH-Mec or Suc-Leu-Leu-Val-Tyr-NH-Mec, were inhibited by peptidyldiazomethanes containing at least three amino acids, including some hydrophobic residues. In general, the dipeptidyl derivatives tested were ineffective, and this probably reflects an extended substrate-binding region at catalytic centres for chymotrypsin-like activity. Cbz-Phe-Gly-Tyr-CHN2 was the best inhibitor of activity assayed with Ala-Ala-Phe-NHMec, whereas several diazomethanes and chloromethanes were effective inhibitors of only 50-70 % of activity assayed with SucLeu-Leu-Val-Tyr-NH-Mec. It seems likely from these results that there are at least two types of catalytic sites able to hydrolyse Suc-Leu-Leu-Val-Tyr-NH-Mec, only one of which is inhibited by Ala-Ala-Phe-CH2Cl or Cbz-Leu-Leu-Tyr-CHN2. Inhibition of both of the chymotrypsin-like activities by the peptidylchloromethane Cbz-Tyr-Ala-Glu-CH2Cl suggests that a hydrophobic residue in the P1 position is not the only determinant of specificity of bond cleavage. The term 'chymotrypsin-like' activity therefore seems to be inappropriate.
The term 'peptidylglutamyl-peptide hydrolase' is also unsuitable on the basis of the inhibitor specificity shown here. CbzTyr-Ala-Glu-CH2Cl does not inhibit either the LLE1 or the LLE2 component, and Cbz-Leu-Leu-Glu-CH2Cl only has a slight inhibitory effect. Both LLE1 and LLE2 components can be inhibited by some reagents containing hydrophobic residues in P1 and P2, and dipeptidyl derivatives seem to be adequate for binding to these sites. Studies of proteasome cleavage sites in peptide substrates (Wilk and Orlowski, 1980; Rivett, 1985; McDermott et al., 1991) have shown that cleavage can occur with many different amino acids in the P1 position, and it is not always easy to predict which catalytic sites are involved.
The trypsin-like activity of the rat liver proteasomes is easily distinguished from the others. Boc-Leu-Ser-Thr-Arg-NH-Mec is one of several suitable substrates the hydrolysis of which is inhibited by some peptidylchloromethane inhibitors containing an arginine residue in the P1 position. Tyr-Gly-Arg-CH2Cl, in particular, has potential as a selective affinity label for trypsinlike activity (P. J. Savory, E. Shaw, K. S. Lilley and A. J. Rivett, unpublished work). The specificity for Arg in the P1 position is also suggested by the observed selective inhibition of this activity by peptidylarginine aldehyde inhibitors, leupeptin and antipain (Rivett, 1989b ). However, it should be noted that peptide aldehyde inhibitors having hydrophobic residues in the P1 position can also inhibit this activity . Moreover, several peptidylchloromethanes with an arginine residue in the P1 position did not inhibit rat liver proteasomes or the rat muscle enzyme (Dahlmann et al., 1985) , suggesting that there are additional structural requirements for binding to this site. The mechanism ofthe time-dependent stimulation of trypsinlike activity of rat liver proteasomes by some affinity-labelling reagents is not clear, but could be explained by modification of a different catalytic site or by an allosteric effect. A similar stimulation of trypsin-like activity of rat liver proteasomes has been noted previously with 3,4-dichloroisocoumarin . Also, a variety of reagents have been found to have effects on activities of the bovine pituitary complex while binding at other sites (see, e.g., Cardozo et al., 1992) .
Several of the inhibitors tested here will be useful in that they can selectively and irreversibly block some catalytic activities while having relatively little effect on others. The results confirm those of studies with serine-proteinase inhibitors, which suggest that rat liver proteasomes contain at least five distinct catalytic centres . The five activities which were assayed seem to be catalysed predominantly at distinct sites, although overlapping specificity of some catalytic centres of proteasomes would not be surprising. In the case of Suc-LeuLeu-Val-Tyr-NH-Mec, the results suggest that the hydrolysis of this substrate occurs at more than one site, because some peptidylchloromethanes and peptidyldiazomethanes have a rapid, but limited, effect on activity. There may be additional catalytic centres which have not yet been identified.
The results of the present studies have provided further insight into the specificity of the different catalytic centres of proteasomes, and it is likely that some of the reagents will be useful in helping to unravel the functions of the many different subunits of the complex.
